FAR 27.204-1
Use of patented technology under the United States-Mexico-Canada Agreement.
When questions arise with regard to use of patented technology under the United States-Mexico-Canada Agreement, the contracting officer should consult with legal counsel. Note that Article 20.6(a) of the Agreement discusses public health and pharmaceuticals.
Source: acquisition.gov — FAR
More parts
Have a solicitation to win?
Paste it into the free Contrax bid scorer — get an AI win-probability score with the FAR clauses that matter, in seconds. No signup required.